| Literature DB >> 32775308 |
Alireza Peyman1, Mehran Hosseini1, Tahmineh Narimani2.
Abstract
BACKGROUND: This study aims to compare the efficacy and toxicity of povidone-iodine (PI) 5%, polyhexamethylene biguanide (PHMB) 0.02%, and chlorhexidine 0.02% in patients undergoing phacoemulsification cataract surgery.Entities:
Keywords: Antiseptic; chlorhexidine; endophthalmitis prophylaxis; phacoemulsification cataract surgery; polyhexamethylene biguanide; povidone-iodine 5%
Year: 2020 PMID: 32775308 PMCID: PMC7282692 DOI: 10.4103/abr.abr_155_19
Source DB: PubMed Journal: Adv Biomed Res ISSN: 2277-9175
Figure 1Trial profile
Baseline patient characteristics in the three groups (n=317)
| Variables | PI 5% ( | PHMB 0.02% ( | Chlorhexidine 0.02% ( |
|---|---|---|---|
| Age (year) | 52.6±13.4 | 55.0±10.7 | 54.4±11.5 |
| Sex | |||
| Male | 64 (59.8) | 54 (51.9) | 57 (53.8) |
| Female | 43 (40.2) | 50 (48.1) | 49 (46.2) |
| Eye | |||
| Left eye | 52 (48.6) | 48 (46.2) | 64 (60.4) |
| Right eye | 55 (51.4) | 56 (53.8) | 42 (39.6) |
Data are mean±SD or n (%). PHMB: Polyhexamethylene biguanide, PI: Povidone-iodine, SD: Standard deviation
Comparison of the positive rate of conjunctival swabs in the three groups (n=317)
| Variables | PI 5% | PHMB 0.02% | Chlorhexidine 0.02% | |
|---|---|---|---|---|
| Blood agar | ||||
| | 107 | 104 | 106 | |
| Before surgery | 37 (34.6) | 40 (38.5) | 39 (36.8) | 0.841 |
| Before surgery | 18 (16.8) | 12 (11.5) | 19 (17.9) | 0.394 |
| | 0.001 | 0.0001 | 0.0001 | |
| Chocolate agar | ||||
| Number | 107 | 104 | 106 | |
| Before intervention | 25 (23.4) | 16 (15.4) | 19 (18.1) | 0.322 |
| After intervention | 6 (5.6) | 0 | 6 (5.7) | 0.058 |
| | 0.0001 | 0.0001 | 0.0001 | |
| Thioglycolate broth | ||||
| | 107 | 104 | 106 | |
| Before intervention | 81 (75.7) | 83 (79.8) | 91 (85.8) | 0.172 |
| After intervention | 63 (58.9) | 65 (62.5) | 73 (68.9) | 0.310 |
| | 0.007 | 0.0001 | 0.001 |
Data are n (%). P values calculated using the Chi-square test. PHMB: Polyhexamethylene biguanide, PI: Povidone-iodine
Comparison of colony-forming units findings among studied groups (n=317)
| Variables | Before intervention | After intervention | ||||
|---|---|---|---|---|---|---|
| PI 5% | PHMB 0.02% | Chlorhexidine 0.02% | PI 5% | PHMB 0.02% | Chlorhexidine 0.02% | |
| Blood agar | ||||||
| | 107 | 104 | 106 | 107 | 104 | 106 |
| 0 | 71 (66.4) | 62 (59.6) | 67 (63.2) | 87 (81.3) | 93 (89.4) | 87 (82.1) |
| 1-10 | 31 (29.0) | 28 (26.9) | 24 (22.6) | 19 (17.8) | 9 (8.7) | 16 (15.1) |
| 11-100 | 5 (4.7) | 14 (13.5) | 15 (14.2) | 1 (0.9) | 2 (1.9) | 3 (2.8) |
| Mean±SD | 1.8±3.6 | 4.8±12.6 | 7.1±20.4 | 0.63±2.0 | 0.53±2.8 | 1.3±4.7 |
| | 0.149 | 0.304 | ||||
| Chocolate agar | ||||||
| | 107 | 104 | 106 | 107 | 104 | 106 |
| 0 | 79 (73.8) | 87 (83.7) | 87 (82.1) | 100 (93.5) | 100 (96.2) | 98 (92.5) |
| 1-10 | 20 (18.7) | 11 (10.6) | 16 (15.1) | 7 (6.5) | 4 (3.8) | 5 (4.7) |
| 11-100 | 8 (7.5) | 6 (5.8) | 3 (2.8) | 0 | 0 | 3 (2.8) |
| Mean±SD | 2.3±7.9 | 2.0±9.9 | 3.5±16.7 | 0.13±0.5 | 0.17±1.1 | 1.3±7.3 |
| | 0.260 | 0.136 | ||||
Data are n (%). P values calculated using the Chi-square test. PHMB: Polyhexamethylene biguanide, PI: Povidone-iodine
Figure 2Comparison of isolated bacteria among the three groups (P = 0.0001). PI: Povidone-Iodine, PHMB: Polyhexamethylene biguanide, Chl.: Chlorhexidine
Comparison of side effects in the three groups (n=317)
| Variables | PI 5% | PHMB 0.02% | Chlorhexidine 0.02% | |
|---|---|---|---|---|
| Conjunctival injection | ||||
| None | 65 (60.7) | 88 (84.6) | 79 (84.0) | 0.0001 |
| Mild/moderate | 37 (34.6) | 16 (15.4) | 15 (16) | |
| Severe | 5 (4.7) | 0 | 0 | |
| Cornea | ||||
| SPE | 32 (29.9) | 7 (6.7) | 0 | 0.0001 |
| No SPE | 75 (70.1) | 97 (93.3) | 94 (100) | |
| Pain | ||||
| None | 43 (40.2) | 87 (83.7) | 81 (86.2) | 0.0001 |
| Mild | 19 (17.8) | 14 (13.5) | 13 (13.8) | |
| Moderate | 28 (26.2) | 3 (2.9) | 0 | |
| Severe | 16 (15) | 0 | 0 | |
| Excruciating | 1 (0.9) | 0 | 0 |
Data are n (%), P values calculated using Chi-square test. PHMB: Polyhexamethylene biguanide, PI: Povidone-iodine, SPE: Superficial punctate epitheliopathy